Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.790
+0.170 (6.49%)
At close: Jun 26, 2026, 4:00 PM EDT
2.840
+0.050 (1.79%)
After-hours: Jun 26, 2026, 7:47 PM EDT

Anixa Biosciences Balance Sheet

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Equivalents
1.481.241.270.9212.3629.13
Short-Term Investments
12.2113.9318.6522.9317.336.6
Cash & Short-Term Investments
13.6915.1719.9223.8429.6935.73
Cash Growth
-12.25%-23.84%-16.44%-19.68%-16.91%294.47%
Accounts Receivable
0.06-0.170.270.05-
Other Current Assets
0.950.711.271.240.470.28
Total Current Assets
14.6915.8921.3625.3630.236
Net Property, Plant & Equipment
0.170.190.230.170.210.25
Total Assets
14.8716.0821.5925.5230.4136.26
Accounts Payable
0.250.170.530.210.270.14
Accrued Expenses
1.211.761.951.771.731.1
Current Portion of Leases
0.040.040.030.050.050.04
Total Current Liabilities
1.51.972.52.032.041.27
Long-Term Leases
0.140.160.20.120.180.22
Total Long-Term Liabilities
0.140.160.20.120.180.22
Total Liabilities
1.642.132.72.152.211.49
Common Stock
0.340.330.320.310.310.3
Treasury Stock
---0.01---
Additional Paid-in Capital
270.89266.51260.43252.22247.12239.93
Retained Earnings
-256.76-251.68-240.75-228.2-218.39-204.79
Total Common Shareholders' Equity
14.4815.162024.3429.0535.44
Minority Interest
-1.25-1.21-1.11-0.97-0.85-0.67
Shareholders' Equity
13.2213.9518.8923.3728.234.77
Total Liabilities & Equity
14.8716.0821.5925.5230.4136.26
Total Debt
0.180.20.230.180.220.26
Net Cash (Debt)
13.514.9719.6923.6729.4735.47
Net Cash Growth
-9.81%-23.98%-16.80%-19.67%-16.92%294.01%
Net Cash Per Share
0.410.460.620.760.971.24
Book Value
14.4815.162024.3429.0535.44
Book Value Per Share
0.440.470.630.790.961.24
Tangible Book Value
14.4815.162024.3429.0535.44
Tangible Book Value Per Share
0.440.470.630.790.961.24
SEC Filings: 10-K · 10-Q